{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:25:58Z","timestamp":1790371558970,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The impact of ABO incompatibility (ABO-I) on hematopoietic stem cell transplant outcomes is still debated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We retrospectively investigated 432 consecutive transplants performed at our center (2012\u20132020). All patients but 6 were affected by hematologic malignancies. The effect of different ABO match combinations on engraftment rate, transfusion support, acute and chronic graft-versus-host disease incidences, nonrelapse mortality (NRM), disease-free survival, and overall survival was assessed in univariate and multivariate analysis. Significance was set at <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>ABO match distribution among transplants was as follows: 223 ABO-compatible, 94 major ABO-I, 82 minor ABO-I, and 33 bidirectional ABO-I. At univariate analysis, major ABO-I delayed the engraftment of neutrophils, platelets, and erythroid cells. At multivariate analysis, major ABO-I transplants displayed delayed erythroid engraftment (odds ratio [OR], 0.51; 95% confidence intervals [CIs], 0.38-0.70; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.0001) and hindered transfusion independence for both red blood cells (OR, 0.52; 95% CI, 0.37-0.72; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.0001) and platelets (0.60; 95% CI, 0.45-0.86; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.0048). Moreover, major ABO-I transplants received greater amounts of blood products (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.0001 for red blood cells and <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.0447 for platelets). In comparison with other ABO matches, major ABO-I was associated with an increased NRM (OR, 1.67; 95% CI, 1.01-2.75; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.0427). No effects of ABO-mismatch were found on graft-versus-host disease, disease-free survival, and overall survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Major ABO mismatch delays multilineage engraftment hinders transfusion independence and increases NRM. The prognostic impact of transfusion burden in hematopoietic stem cell transplantation deserves to be explored.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001179","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T18:00:07Z","timestamp":1625853607000},"page":"e724","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes"],"prefix":"10.1097","volume":"7","author":[{"given":"Caterina Giovanna","family":"Valentini","sequence":"first","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Metafuni","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Gallo","sequence":"additional","affiliation":[{"name":"Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Giammarco","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Orlando","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."},{"name":"Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bacigalupo","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."},{"name":"Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Chiusolo","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."},{"name":"Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Teofili","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d IRCCS, Rome, Italy."},{"name":"Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.transci.2016.05.010","article-title":"An update on ABO incompatible hematopoietic progenitor cell transplantation.","volume":"54","author":"Staley","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2013.03.018","article-title":"Clinical guide to ABO-incompatible allogeneic stem cell transplantation.","volume":"19","author":"Booth","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/bmt.2011.135","article-title":"Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.","volume":"46","author":"Rowley","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/trf.13353","article-title":"ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.","volume":"56","author":"Hefazi","year":"2016","journal-title":"Transfusion"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbmt.2017.02.009","article-title":"Donor-to-recipient ABO mismatch does not impact outcomes of allogeneic hematopoietic cell transplantation regardless of graft source.","volume":"23","author":"Damodar","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ajh.24771","article-title":"ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: a report from the acute leukemia working party of the EBMT.","volume":"92","author":"Canaani","year":"2017","journal-title":"Am J Hematol"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2016.160804","article-title":"Impact of ABO incompatibility on patients\u2019 outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia\u2014a report from the Acute Leukemia Working Party of the EBMT.","volume":"102","author":"Canaani","year":"2017","journal-title":"Haematologica"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41409-019-0496-2","article-title":"ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantation.","volume":"54","author":"Kimura","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.13356","article-title":"Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.","volume":"94","author":"Stussi","year":"2009","journal-title":"Haematologica"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41409-020-01124-6","article-title":"Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.","volume":"56","author":"Marco-Ayala","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41409-020-0779-7","article-title":"Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia.","volume":"55","author":"Ma","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbmt.2014.12.036","article-title":"ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation.","volume":"21","author":"Logan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the disease risk index for allogeneic stem cell transplantation.","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajh.26042","article-title":"Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: the role of the conditioning regimen.","volume":"96","author":"Chiusolo","year":"2021","journal-title":"Am J Hematol"},{"key":"R16-20240805","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading.","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease.","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcyt.2020.01.007","article-title":"Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes?","volume":"22","author":"Teofili","year":"2020","journal-title":"Cytotherapy"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V96.3.1150","article-title":"Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.","volume":"96","author":"Mielcarek","year":"2000","journal-title":"Blood"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbmt.2010.03.021","article-title":"Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.","volume":"16","author":"Blin","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0463.2000.d01-1.x","article-title":"Tissue distribution of histo-blood group antigens.","volume":"108","author":"Ravn","year":"2000","journal-title":"APMIS"},{"key":"R24-20240805","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/trf.14966","article-title":"Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993\u20132010): factors that predict intensity and time to transfusion independence.","volume":"59","author":"Griffith","year":"2019","journal-title":"Transfusion"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbmt.2016.02.008","article-title":"Pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplantation is associated with severe pancytopenia.","volume":"22","author":"Aung","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1182\/blood.V112.11.2157.2157","article-title":"Impact of donor\/recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source: results from an 809-patient retrospective study.","volume":"112","author":"Blin","year":"2008","journal-title":"Blood"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00007890-198806000-00018","article-title":"ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.","volume":"45","author":"Bacigalupo","year":"1988","journal-title":"Transplantation"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbmt.2009.11.011","article-title":"Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.","volume":"16","author":"Kasamon","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1537-2995.2008.02043.x","article-title":"Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.","volume":"49","author":"Kanda","year":"2009","journal-title":"Transfusion"},{"key":"R30-20240805","first-page":"1","article-title":"Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis.","author":"Petrelli","year":"2021","journal-title":"Surg Today"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding.","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2352-3026(15)00198-2","article-title":"Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis.","volume":"2","author":"Patel","year":"2015","journal-title":"Lancet Haematol"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.","volume":"340","author":"H\u00e9bert","year":"1999","journal-title":"N Engl J Med"},{"key":"R34-20240805","doi-asserted-by":"crossref","first-page":"e204095","DOI":"10.1001\/jamasurg.2020.4095","article-title":"Development and validation of a comprehensive model to estimate early allograft failure among patients requiring early liver retransplant.","volume":"155","author":"Avolio","year":"2020","journal-title":"JAMA Surg"},{"key":"R35-20240805","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tmrv.2013.01.001","article-title":"Innate immune activation after transfusion of stored red blood cells.","volume":"27","author":"Neal","year":"2013","journal-title":"Transfus Med Rev"},{"key":"R36-20240805","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.htct.2020.03.003","article-title":"Implications of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response.","volume":"43","author":"Aguilar-Nascimento","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"key":"R37-20240805","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/trf.15952","article-title":"Effect of repeat transfusion exposure on plasma cytokine and markers of endothelial activation in the extremely preterm neonate.","volume":"60","author":"Crawford","year":"2020","journal-title":"Transfusion"},{"key":"R38-20240805","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/ALN.0b013e31822a22d9","article-title":"Reducing noninfectious risks of blood transfusion.","volume":"115","author":"Gilliss","year":"2011","journal-title":"Anesthesiology"},{"key":"R39-20240805","doi-asserted-by":"crossref","first-page":"e10310","DOI":"10.1097\/MD.0000000000010310","article-title":"Effect of pre-transplantation serum ferritin on outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R40-20240805","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bbmt.2012.10.012","article-title":"Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.","volume":"19","author":"Meyer","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R41-20240805","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00277-020-04363-1","article-title":"Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.","volume":"100","author":"Fingrut","year":"2021","journal-title":"Ann Hematol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:07:26Z","timestamp":1722834446000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001179","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}